Company: AMB HK ENTERPRISES INC; CORBRIDGE GROUP PHILS., INCLast updated:Audience: Licensed health professionals
Registered with the Philippine FDA as a FOOD SUPPLEMENT — no approved therapeutic claims. Not a substitute for prescribed treatment.
CKD · dialysis · transplant
Kidney notes
Renakult is a probiotic with the same three organisms as Renadyl (Lactobacillus acidophilus, Bifidobacterium longum, Streptococcus thermophilus); one of its two Philippine registrations also lists Bacillus coagulans. Strain designations and colony counts are not given in the FDA record.
Evidence
No clinical trials of Renakult itself were identified on PubMed.
Its species overlap with Renadyl, whose small trials showed lower BUN in CKD stages 3 to 4 but no significant change in uremic toxins or quality of life on hemodialysis (Ranganathan 2009; Natarajan 2014). Probiotic effects are strain- and dose-specific, so these results cannot be transferred to Renakult.
Class evidence: probiotics alone did not lower indoxyl sulfate or p-cresyl sulfate in a meta-analysis of RCTs (Chen 2022), and biotic supplements did not lower serum creatinine in non-dialysis CKD (Liu 2023).
Cautions in kidney disease
Probiotic organisms can enter the bloodstream: whole-genome sequencing has linked Lactobacillus bacteremia in ICU patients to the probiotic capsule they were given. Avoid in critically ill patients, those with a central venous catheter (including a tunneled hemodialysis catheter), recent bowel surgery or gut barrier injury, and in kidney transplant recipients or others on immunosuppression unless the treating team agrees. [Yelin 2019]
Trial outcomes were blood urea nitrogen (BUN), creatinine, uremic-toxin levels and quality-of-life scores; no trial reports kidney failure, dialysis start, cardiovascular events or death.
Registered as a food supplement with no approved therapeutic claims: viable count, strain identity and storage stability are not verified by the FDA the way drug content is.
It does not replace evidence-based CKD care (blood pressure and glucose control, RAAS blockade, SGLT2 inhibitors where indicated, diet).
Bottom line
No product-specific evidence; class evidence is limited to surrogate markers. Same safety limits as any live probiotic, especially in transplant recipients and patients with a dialysis catheter.
Sources
Ranganathan, N., Friedman, E. A., Tam, P., Rao, V., Ranganathan, P., & Dheer, R. (2009). Probiotic dietary supplementation in patients with stage 3 and 4 chronic kidney disease: A 6-month pilot scale trial in Canada. Current Medical Research and Opinion, 25(8), 1919–1930. https://doi.org/10.1185/03007990903069249
Natarajan, R., Pechenyak, B., Vyas, U., Ranganathan, P., Weinberg, A., Liang, P., Mallappallil, M. C., Norin, A. J., Friedman, E. A., & Saggi, S. J. (2014). Randomized controlled trial of strain-specific probiotic formulation (Renadyl) in dialysis patients. BioMed Research International, 2014, 568571. https://doi.org/10.1155/2014/568571
Chen, L., Shi, J., Ma, X., Shi, D., & Qu, H. (2022). Effects of microbiota-driven therapy on circulating indoxyl sulfate and p-cresyl sulfate in patients with chronic kidney disease: A systematic review and meta-analysis of randomized controlled trials. Advances in Nutrition, 13(4), 1267–1278. https://doi.org/10.1093/advances/nmab149
Liu, F., Liu, Y., Lv, X., & Lun, H. (2023). Effects of prebiotics, probiotics and synbiotics on serum creatinine in non-dialysis patients: A meta-analysis of randomized controlled trials. Renal Failure, 45(1), 2152693. https://doi.org/10.1080/0886022X.2022.2152693
Yelin, I., Flett, K. B., Merakou, C., Mehrotra, P., Stam, J., Snesrud, E., Hinkle, M., Lesho, E., McGann, P., McAdam, A. J., Sandora, T. J., Kishony, R., & Priebe, G. P. (2019). Genomic and epidemiological evidence of bacterial transmission from probiotic capsule to blood in ICU patients. Nature Medicine, 25(11), 1728–1732. https://doi.org/10.1038/s41591-019-0626-9
Reviewed by William Gregory M. Rivero, MD, FPCP, DPSN on November 17, 2026. renalcarematters.com, reviewed
FDA Philippines registrations
2 current food-supplement registrations under the brand RENAKULT. Registration status changes;
confirm a product's current status on the FDA verification portal using its FR number.
For health professionals. Data come from the FDA Philippines food-product
registration database and may lag behind the official record. A food-supplement registration means the product may be sold as food; it is not an approval of safety or efficacy for any disease. Not a substitute for clinical judgment.